Status:
TERMINATED
Amphotericin-B and Voriconazole for Pulmonary Blastomycosis
Lead Sponsor:
University of Manitoba
Collaborating Sponsors:
Pfizer
Conditions:
Blastomycosis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
All patients with pulmonary blastomycosis requiring mechanical ventilation will have their blood concentrations measured for the antifungal drugs, amphotericin-B and voriconazole; as well as an analys...
Detailed Description
To evaluate six intensively studied patients admitted to medical intensive care with pulmonary blastomycosis requiring mechanical ventilation. Interventionally, all patients will receive continuously ...
Eligibility Criteria
Inclusion
- All adult patients 18 years of age or older admitted to the intensive care units of St. Boniface General Hospital with a diagnosis of acute pulmonary blastomycosis requiring mechanical ventilation.
Exclusion
- The patient's data will be excluded if they die within 3 days of hospital admission.
Key Trial Info
Start Date :
June 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 25 2020
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT02283905
Start Date
June 1 2015
End Date
September 25 2020
Last Update
September 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Boniface General Hospital
Winnipeg, Manitoba, Canada, R2H 2A6